VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Autodesk, Inc. vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Autodesk, Inc.
ADSK · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Autodesk, Inc.'s moat claims, evidence, and risks.
View ADSK analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Autodesk, Inc. leads (69 / 100 vs 62 / 100 for GSK plc).
- Segment focus: Autodesk, Inc. has 5 segments (47.9% in Architecture, Engineering, Construction and Operations (AECO)); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Autodesk, Inc. has 7 moat types across 2 domains; GSK plc has 4 across 3.
Primary market context
Autodesk, Inc.
Architecture, Engineering, Construction and Operations (AECO)
Architecture, engineering, construction & operations (AECO) software (BIM, civil design, construction management)
Global
B2B / professional
Software vendor (design + construction workflow platform)
47.9%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Autodesk, Inc. strengths
GSK plc strengths
Segment mix
Autodesk, Inc. segments
Full profile >Architecture, Engineering, Construction and Operations (AECO)
Oligopoly
AutoCAD and AutoCAD LT
Quasi-Monopoly
Manufacturing (MFG)
Oligopoly
Media and Entertainment (M&E)
Competitive
Other (Consulting and other products/services)
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.